Reply: Replicating studies of genetic modifiers in spinocerebellar ataxia type 3: can homogeneous cohorts aid?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

1 citing paper in PubMed.

1. Co-occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades.Molecular genetics & genomic medicine · 2019
   Article

Corrections and comments

• Comment on
  Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.2014
• Comment on
  Replicating studies of genetic modifiers in spinocerebellar ataxia type 3: can homogeneous cohorts aid?2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as